U.S. flag

An official website of the United States government

NM_000061.3(BTK):c.1688G>A (p.Trp563Ter) AND X-linked agammaglobulinemia with growth hormone deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000702940.6

Allele description [Variation Report for NM_000061.3(BTK):c.1688G>A (p.Trp563Ter)]

NM_000061.3(BTK):c.1688G>A (p.Trp563Ter)

Gene:
BTK:Bruton tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.1
Genomic location:
Preferred name:
NM_000061.3(BTK):c.1688G>A (p.Trp563Ter)
HGVS:
  • NC_000023.11:g.101353932C>T
  • NG_009616.1:g.37293G>A
  • NG_011734.1:g.38G>A
  • NM_000061.3:c.1688G>AMANE SELECT
  • NM_001287344.2:c.1790G>A
  • NM_001287345.2:c.1160G>A
  • NP_000052.1:p.Trp563Ter
  • NP_000052.1:p.Trp563Ter
  • NP_001274273.1:p.Trp597Ter
  • NP_001274274.1:p.Trp387Ter
  • LRG_128t1:c.1688G>A
  • LRG_128:g.37293G>A
  • LRG_128p1:p.Trp563Ter
  • NC_000023.10:g.100608920C>T
  • NM_000061.2:c.1688G>A
Protein change:
W387*
Links:
dbSNP: rs1555977474
NCBI 1000 Genomes Browser:
rs1555977474
Molecular consequence:
  • NM_000061.3:c.1688G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001287344.2:c.1790G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001287345.2:c.1160G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
X-linked agammaglobulinemia with growth hormone deficiency (IGHD3)
Synonyms:
IGHD III; Isolated growth hormone deficiency type 3; Growth hormone deficiency with hypogammaglobulinemia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010615; MedGen: C0472813; Orphanet: 631; OMIM: 307200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000831817Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 22, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.

Holinski-Feder E, Weiss M, Brandau O, Jedele KB, Nore B, Bäckesjö CM, Vihinen M, Hubbard SR, Belohradsky BH, Smith CI, Meindl A.

Pediatrics. 1998 Feb;101(2):276-84.

PubMed [citation]
PMID:
9445504

Genetic analysis of patients with defects in early B-cell development.

Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, Shurtleff SA.

Immunol Rev. 2005 Feb;203:216-34. Review.

PubMed [citation]
PMID:
15661032
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV000831817.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 579604). This premature translational stop signal has been observed in individual(s) with X-linked agammaglobulinemia (XLA) (PMID: 9445504). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp563*) in the BTK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BTK are known to be pathogenic (PMID: 15661032, 16862044, 19419768).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 14, 2024